Skip to NavigationSkip to content

News

Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide...
Life expectancy has fallen for the first time in 35 years in Scotland, as data released by the National Records of Scotland has revealed that life...
Pascal Soriot, the Chief Executive Officer of the Anglo-Swedish multinational AstraZeneca, has raised concerns that he is being underpaid, despite...
Lack of access to CAR T therapies in the United Kingdom could hinder the development of effective personalised cancer treatments, according to the...
President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight against drugs around the...
Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive non-small cell lung...
Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s most deadly...
Swiss multinational Novartis are set to cut thousands of jobs across Europe in an effort to boost profitability. The move comes as part of a major...
AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as a...
The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report released by the Kirby Institute.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches